Back to top

Image: Bigstock

The Zacks Analyst Blog Highlights: Stamps.com, Etsy, Daqo New Energy, Emergent BioSolutions and Atlas Air Worldwide

Read MoreHide Full Article

For Immediate Release

Chicago, IL – September 2, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Stamps.com Inc. (STMP - Free Report) , Etsy, Inc. (ETSY - Free Report) , Daqo New Energy Corp. (DQ - Free Report) , Emergent BioSolutions Inc. (EBS - Free Report) and Atlas Air Worldwide Holdings, Inc. (AAWW - Free Report)

Here are highlights from Tuesday’s Analyst Blog:

This September Could Be Different: 5 Stocks to Buy

It’s been a superb August for major stock indexes, the best month since the market rebounded in April from the pandemic lows hit in March. The broader S&P 500 climbed 7% last month, its best August performance since the 1980s. Similarly, the Dow and the Nasdaq rose 7.6% and 9.6%, respectively, in the month.

The month’s best performer no doubt has been tech, but there has also been a partial rebound in industries impacted by the coronavirus pandemic, including cruise liners, airlines, casino operators and hotels.

However, now the stock market is about to begin a historically challenging September. After all, since World War II, the S&P 500 on average declined 0.5% in the month of September, according to CFRA research company.

In fact, the Dow averaged a loss of 1% in September since 1937, while the Nasdaq, since its inception in 1971, averaged a loss of 0.5%, per Dow Jones Market Data.

What’s worse, the general belief is that stocks tend to lose further in September of election years since there is potential for even more volatility. However, that’s not the case. Since 1896, during presidential election years, the average return for the Dow has actually been positive. Have a look at the diagram –

And in case of the S&P 500, whenever the broader index has gained more than 5% in August, September gained an average 1.4%, according to Sam Stovall, chief investment strategist at CFRA.

Moreover, September’s reputation of being an awful month for stocks is also baffling as there is no convincing theory behind it.

Some say that since 1990, tax-loss selling from mutual funds resulted in a dismal September. But actually, Dow’s average loss prior to 1990 has been four times more than what it has been since then.

And let’s admit, there are plenty of reasons why one shouldn’t stay away from stocks this September. Stocks are expected to gain on optimism surrounding further stimulus from Washington and progress on a coronavirus vaccine.

U.S. lawmakers are expected to return to work in September after a recess in August. They are widely expected to resume talks to end a gridlock on a new coronavirus stimulus package, which will eventually benefit both consumers and businesses.

Investors, in the meantime, also anticipate that the world will finally overcome the COVID-19 pandemic in the near term, thanks to positive news on multiple vaccines in various stages of testing. Notable among them are the ones being jointly developed by the University of Oxford and AstraZeneca, and Pfizer with its partner BioNTech.

Last but not the least, the Fed’s latest policy shift, not to ratchet up rates to counter higher inflation anytime soon, has helped buoy investor optimism.

5 Best Stocks to Buy for September

Given the aforesaid positives, it’s expected that August’s momentum will continue into September. Banking on such bullish sentiments, investing in sound stocks poised to grow in the current period and beyond seems prudent. These stocks flaunt a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Stamps.com is a leading provider of Internet-based postage services. The Zacks Consensus Estimate for its current-year earnings has risen 57.6% over the past 60 days. The company’s expected earnings growth rate for the current quarter and year is 10.7% and 28.5%, respectively. So far this year, the company’s shares have soared 202.6%.

Etsy offers e-commerce services. It provides online and offline marketplaces to buy and sell goods. The Zacks Consensus Estimate for its current-year earnings has climbed 88.1% over the past 60 days. The company’s expected earnings growth rate for the current quarter and year is 375% and 169.8%, respectively. So far this year, the company’s shares have surged 170.1%.

DAQO New Energy is engaged in the manufacture and sale of high-quality polysilicon to photovoltaic product manufacturers. The Zacks Consensus Estimate for its current-year earnings has climbed 50.5% over the past 60 days. The company’s expected earnings growth rate for the current quarter and year is 664.7% and 348.5%, respectively. The company’s shares have climbed 144.5% year to date.

Emergent Biosolutions is a specialty biopharmaceutical company that aims to offer specialized products to health care providers and governments to fulfil unmet medical needs and combat emerging public health threats. The Zacks Consensus Estimate for its current-year earnings has moved 83.2% north over the past 60 days. The company’s expected earnings growth rate for the current quarter and year is 57.9% and 117.2%, respectively. The company’s shares have jumped 118% year to date.

Atlas Air Worldwide is the parent company of Atlas Air and Polar Air Cargo, which together operate the world's largest fleet of Boeing freighter aircraft. The Zacks Consensus Estimate for its current-year earnings has risen 37.7% over the past 60 days. The company’s expected earnings growth rate for the current quarter and year is 532.4% and 122.3%, respectively. So far this year, the company’s shares have rallied 107.4%.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com                                      

https://www.zacks.com                                                   

 

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.